Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Inflammatory Bowel Diseases|December 14, 2002
Response of refractory colitis to intravenous or oral tacrolimus (FK506)Klaus Fellermann, Zita Tanko, Klaus R Herrlinger, et al.
Inflammatory Bowel Diseases|August 5, 2004
Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitisKlaus R Herrlinger, Rike Dittmann, Gunther Weitz, et al.
Inflammatory Bowel Diseases|August 7, 2003
Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitisJan Wehkamp, Juergen Harder, Michael Weichenthal, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|June 19, 2002
[Evidence-based guideline for the diagnosis and treatment of ulcerative colitis]Eduard F Stange
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Current and future aspects of IBD research and treatment: The 2022 perspectiveEduard F Stange
Digestive Diseases (Basel, Switzerland)|February 2, 2017
Improvement of a 'Leaky' Intestinal BarrierEduard F Stange
Frontiers in Medicine|June 7, 2024
Dysbiosis in inflammatory bowel diseases: egg, not chickenEduard F Stange
European Journal of Gastroenterology & Hepatology|August 10, 2002
Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel diseaseJan Wehkamp, Klaus Fellermann, Klaus R Herrlinger, et al.
Digestive Diseases (Basel, Switzerland)|November 20, 2013
Differences between treatment guidelines--GermanyKlaus R Herrlinger
Pageof 12